Impact Factor 4.848 | CiteScore 3.5
More on impact ›
in Oncology |
|
Submit your manuscript
Scope
The Cancer Metabolism section is aimed at the basic, translational and clinical study of energy metabolism and metabolic reprogramming in cancer cells. Research pertaining but not limited to altered metabolic pathways, development of metabolically-targeted pharmacological therapies, as well as metabolic changes affecting the tumor microenvironment is welcome.
Read More
Scope
This section of the journal will focus on the basic science, translational and clinical aspects of Cancer Metabolism, with a particular emphasis on energy metabolism and metabolic reprogramming in cancer cells. This broadly includes mitochondrial, glycolytic, fatty acid, as well as other forms of metabolism. We are also interested in how driver mutations, gene expression and epigenetic regulation influence metabolism in cancer cells.
Novel research will be considered for this section which is pertaining to metabolic reprogramming, metabolic flexibility, altered pathways of metabolism, tumor initiation, progression and metastasis, EMA/FDA-approved drug repurposing, development of new pharmacological therapies, as well as metabolic changes affecting the tumor microenvironment. Of particular interest is research on induction of metabolic inflexibility in cancer cells, and methods of targeting such cells for effective treatment.
We aim to provide a supportive and constructive framework to facilitate the development and implementation of new metabolic therapies, with the goal of preventing treatment failure (recurrence and metastasis), which is largely due to metabolic flexibility or plasticity in cancer cells, while minimizing the side-effects of cancer therapy. This section welcomes clinical aspects of research, as well as basic and translational studies in the subject.
Indexed in: PubMed, PubMed Central (PMC), Scopus, Google Scholar, DOAJ, CrossRef, Chemical Abstracts Service (CAS), CLOCKSS
PMCID: all published articles receive a PMCID
Cancer Metabolism welcomes submissions of the following article types: Case Report, Clinical Trial, Correction, Editorial, General Commentary, Hypothesis and Theory, Mini Review, Original Research, Perspective, Review, Specialty Grand Challenge and Systematic Review.
All manuscripts must be submitted directly to the section Cancer Metabolism, where they are peer-reviewed by the Associate and Review Editors of the specialty section.
Frontiers Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
Frontiers Support
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
support@frontiersin.org
There are no results to display.
Click on any of the keywords to find further editors related to it.
- Article(s) found
- Latest
- Most viewed
This section has no articles.
There are no articles to display. Please try changing the filters.
- Research Topic(s) found
- Latest
- Most viewed
Contact Editorial Office
Avenue du Tribunal Fédéral 34
CH – 1005 Lausanne
Switzerland
Tel +41(0)21 510 17 40
Fax +41 (0)21 510 17 01
For all queries regarding manuscripts in Review and potential conflicts of interest, please contact oncology.editorial.office@frontiersin.org
For queries regarding Research Topics, Editorial Board applications, and journal development, please contact oncology@frontiersin.org
Tel +41(0)21 510 17 10
Fax +41 (0)21 510 17 01
For technical issues, please visit our Frontiers Help Center, or contact our IT HelpDesk team at support@frontiersin.org